chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Two days after the injection on Thursday 1/20/2022, there was swelling at the site and redness and also redness below the site in the lower muscle (above the elbow).  Then on Friday 1/21/2022, the swelling at the site had subsided but there was still swelling and redness at the muscle site below that went from side to side of the forearm there. It has continued but seems to be lessening a little today, 1/22/2022. I have been able to use the arm without problems but it does ache, which I believe is due to the swelling.
She has history of seizures and was given the vaccine and then had a seizure. She was transferred to  local ER for further evaluation. She was given Ativan and has been discharged.
Pt was 06/20/1997 and Aug 21, 1997 was vaccinated with the first and second doses, respectively, of varicella. Concomitant vax on Jun 6, 1997 and July 8,1997 included the first and second doses, respectively of heb B vax. Other concomitant medications included loratadine and ethinyl norethindrone acetate.  On 5/20/99, the pt had an antibody test that revealed a failure to seroconvert.
Patient had a 3rd dose of the Moderna COVID-19 vaccine administered. Patient was advised (by unknown healthcare provider) to restart the Moderna COVID-19 vaccine two dose series because she contracted the COVID-19 disease after her first dose, but before the second dose was scheduled. Her 1st dose was administered on 1/26/2021; she was diagnosed with COVID on 2/5/2021 and admitted to hospital; restarted the series on 5/25/2021 (2nd dose); and received a 3rd dose on 6/22/2021.
Patient walked into the vaccination room to receive J&J COVID-19 vaccine. Patient was counselled on side effects. Patient looked slightly pale and mentioned he did not like vaccines. Patient was administered the J&J vaccine in left deltoid. Immediately after administering the vaccine, a band-aid was placed on the injection site and as the band-aid was being placed, the pharmacist heard the patient exhale and noticed the patient's head dropped to the side. Pharmacist caught the patient's head and held it while repeating his name until he woke up. Patient lost consciousness for about 15-20 seconds. When patient awoke, he was asked if he was okay and he replied "I went to sleep". He mentioned this has happened to him recently when he had to give blood work and another time he asked to leave the hospital room after feeling queasy when his wife had to be given an epidural. Patient denied any shortness of breath/difficulty breathing, chest pains, or itching. He was provided with water and an ice pack to apply to the back of his neck. The color immediately came back to his face after drinking some water and applying the ice pack. While observing him, we discussed he has a 3 month old baby and has not been getting any sleep lately and the only ?symptom? he felt was sleepy. He was observed for 15 additional minutes inside the vaccination room without any further events.
On 03/26/21 at approx. 1730 pm, 9 days post vaccination, HCW reported noticing a small light pink rash   over left deltoid muscle area. Per HCW, rash has increased in size.  Rash is asymmetrical in shape and currently  measures 130 mm x 70 mm or approx. 5x3 inches. Area is warm to touch.  No swelling, pain, break in skin integrity.  HCW denies presence of rash elsewhere on body.   Denies itching/scratching area.    Had mild pain initially at injection site that resolved 1 day post injection.   Denies CP, SOB, or N/V.   PLAN:  Coordination for further evaluation.  HR Coordinator notified and will coordinate an appointment for the HCW to be evaluated at Health Clinic.
diagnosed with shingles; This spontaneous case was reported by a patient and describes the occurrence of HERPES ZOSTER (diagnosed with shingles) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 052E21A, 035C21-2, 001A21A and 012M20A) for COVID-19 vaccination.    Co-suspect product included non-company product MYCOPHENOLATE MOFETIL for Autoimmune hepatitis.    Patient was not tested or diagnosed with COVID-19.  Concurrent medical conditions included Autoimmune hepatitis.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Jun-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient started MYCOPHENOLATE MOFETIL (unknown route) 1500 microgram once a day. On an unknown date, the patient experienced HERPES ZOSTER (diagnosed with shingles). At the time of the report, HERPES ZOSTER (diagnosed with shingles) outcome was unknown.            The patient got shingles from a medication mycophenolate mofetil) which the patient was taking for autoimmune hepatitis.  The patient was due for the second booster but had shingles.  No treatment medication were provided.
Ended up falling down; did not feel crappy until she was getting up/wave of not feeling well; got really lightheaded; ended up passing out on the floor; arm was really hurting; really bad headache; This spontaneous case was reported by a patient and describes the occurrence of LOSS OF CONSCIOUSNESS (ended up passing out on the floor) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    No Medical History information was reported.  On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced PAIN IN EXTREMITY (arm was really hurting) and HEADACHE (really bad headache). On 06-May-2021, the patient experienced LOSS OF CONSCIOUSNESS (ended up passing out on the floor) (seriousness criterion medically significant), FALL (Ended up falling down), VACCINATION COMPLICATION (did not feel crappy until she was getting up/wave of not feeling well) and DIZZINESS (got really lightheaded). At the time of the report, LOSS OF CONSCIOUSNESS (ended up passing out on the floor), PAIN IN EXTREMITY (arm was really hurting), FALL (Ended up falling down), VACCINATION COMPLICATION (did not feel crappy until she was getting up/wave of not feeling well), DIZZINESS (got really lightheaded) and HEADACHE (really bad headache) outcome was unknown.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Concomitant medication information not provided. Treatment information not provided.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Moderate fussiness X 2 hours with onset 4 hours, post vax. Pt checked about 5 hours, post vax, and without increase of temperature and looked well. On recheck, 1 day, post vax, pt was smiling and alert with 3, 1/2cm indurated areas at vaccine sites.
3" x 2" reddened raised welt area with significant headache the next day.
I experienced pounding headache, severe fatigue and sore and swollen left arm. At 12 noon on Thursday, I took 2 tylenol for arthritis and laid down at 2 pm woke up at 8pm and felt slight relief the pain was not as intense, but still present. The symptoms persisted Friday and on Saturday milder and then with the exception of sore and swollen left arm other symptoms resolved around 2 pm on Saturday afternoon. I did have the virus in March, 2020 (pneumonia, pulmonary embolism) treated and resolved. Also, I am a participant in an antibody study and tested in December , 2020 and did show I was still positive for covid19 antibodies. I am very concerned about taking the 2nd vaccine scheduled 3/31/21. Please advise.
She developed red rash on the right arm when the injection took place.  No fever, minimal chills.  No vesicles.  no headaches, No neurological signs or symptoms.
Onset of injection site soreness, muscle soreness, flu like body aches, mild fever, headache, stomach ache all lasting up to 72 hours after injection.
tinge of a headache; aching all over body; fever of 101.1; cough; weakness; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (tinge of a headache), PAIN (aching all over body), PYREXIA (fever of 101.1), COUGH (cough) and ASTHENIA (weakness) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002B21A and 11M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (tinge of a headache), PAIN (aching all over body), PYREXIA (fever of 101.1), COUGH (cough) and ASTHENIA (weakness). At the time of the report, HEADACHE (tinge of a headache), PAIN (aching all over body), PYREXIA (fever of 101.1), COUGH (cough) and ASTHENIA (weakness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.1 (High) 101.1.         Concomitant product use was not provided by the reporter. Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not Applicable.
Minor swelling and tenderness at left submandibular nodes beginning 24 hours after vaccination.  Resolved after 24 hours.
Rash on face, swelling on face, headache, fatigue. All went away by Monday 8-6-18.
Patient immediately after vaccine reported anxiety and difficulty talking. Patient took dose of children's Benadryl from home. States she has had this feeling before when exposed to chemical smells. After 10 minutes patient states symptoms are improving. Encouraged to stay for monitoring for additional 30 minutes. After around 5 minutes, the patient notified staff of symptoms reoccuring and worsening. States she is having shortness of breath, chest tightness and difficulty talking. Patietn evaluated and taken to ED for further treatment. Clinic provider notified.
At 5:00pm; upon arrival noticed client was laying on floor,assessed mental status,client was alert and oriented x3,checked vital signs,vital signs was stable,ice pack placed on client.Noticed client was sweating, c/o of dizziness,assisted to laying to lay down a safely.assess head for injury,no injury was noticed. at 5:15pm; client was assisted up,hdration was provided. and assisted out to his car.
fever; headache; This is a spontaneous report from a contactable consumer (patients husband). A female patient of an unspecified age received bnt162b2 (BNT162B2, solution for injection), dose 1 via an unspecified route of administration on 10Feb2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Reporter stated that his wife experienced fever and headache (date unknown) after the 1st. His wife already took 2 Aspirins and would like to ask if taking Amoxicillin will interfere with the 1st dose vaccine. The outcome for both the events was unknown.  Follow-up attempts completed. No further information expected.
Sudden fatigue; mild arm soreness; mild headache; This is a spontaneous report from a contactable Consumer (patient).  A 41-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: unknown), via an unspecified route of administration, in Left Arm on 25Feb2021 at 12:00 (at 41 years) at single dose for covid-19 immunisation . Medical history included Wegener's Granulomatosis, asthma, osteoarthritis (OA) and more (as reported). Patient had known allergy to trazodone and temazepam (RESTORIL). Concomitant medications (in two weeks) included multi vitamin, omeprazole (PROTONIX), azathioprine (IMURAN), clopidogrel bisulfate (PLAVIX), rosuvastatin calcium (CRESTOR).  On 26Feb2021at 13:00 the patient experienced Sudden fatigue, mild arm soreness and mild headache. No treatment given. The outcome of the events was recovering. No follow up attempts are possible; information on Lot/batch number cannot be obtained.
pain in the area of the shot / upper left arm / pain of various degrees ranging from an annoyance to a degree of pain that will...and has...awakened me at night; degree of pain that will...and has...awakened me at night.; This case was reported by a consumer and described the occurrence of injection site pain in a 77-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th July 2020, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced injection site pain and wakefulness. On an unknown date, the outcome of the injection site pain and wakefulness were unknown.   It was unknown if the reporter considered the injection site pain and wakefulness to be related to Shingrix.  Additional details were reported as follows: The case was reported by patient herself/ himself. The patient received Shingrix vaccine in left upper arm and experienced pain in the area of the shot. The patient reported that this was a pain of various degrees ranging from an annoyance to a degree of pain that awakened patient at night. The patient did not take anything for it and just let it work itself out. The patient stated that if there were reported side effects of Shingrix vaccine, then add his/her experience to it.
About 12 hours after vaccine -  migraine, nausea, chills, high heart rate, sweating , sore arm At around 24 hours - migraine, sore arm but other symptoms gone. At around 36 hours - all symptoms gone besides slightly sore arm around vaccine site.
Pfizer COVID-19 bivalent booster (gray cap) administered 2 days after "beyond use date".  No known adverse effects on patient.
rash on back and chest mainly; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on back and chest mainly) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No reported medical history.  Concomitant products included METFORMIN, ATORVASTATIN, LEVOTHYROXINE, DOXYCYCLINE, VITAMIN B12 NOS, ACETYLSALICYLIC ACID (BABY ASPIRIN) and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Mar-2021, the patient experienced RASH (rash on back and chest mainly). At the time of the report, RASH (rash on back and chest mainly) outcome was unknown.            Concomitant products includes inhaler, and multivitamin. treatment medication include cream on the area.
Immunization was given at an employee flu shot clinic. Was given very high up on left arm, almost at shoulder joint. Arm and shoulder began to ache 10-12 hrs after shot which I assumed was normal tenderness experienced after this immunization. However over the next few days the tenderness in the arm resolved but the shoulder joint pain persisted, making moving the joint difficult. Pain is relieved by taking 800 mg ibuprofen, but reoccurs 5-6 hrs after taking dose. On 9/29/14 I reported the above to the facility's occupational health nurse who sent me to the facility's occupational health clinic on 10/3/14. The doctor did not prescribe any treatment, stated pain was not due to the immunization and declined to file a VAERS report. At this time, I am still experiencing the shoulder pain which is temporarily relieved by 800 mg ibuprofen.
Redness/inflammation/itchiness around both eyes.  The areas primarily affected are the skin tissue just below both eyes and the skin tissue at the inner and outer bilat corners. The eyelids themselves do not have a red/inflammed appearance, however they itch. These symptoms appeared the same day the H1N1 vaccination was administered and persisted approx 2-3 days subsequent to it. Symptoms then subsided for a few weeks, returning again on the evening of 12/24/2009.  The aforementioned symptoms were not present prior to the vaccine and this individual has had no history of a similar reaction.  The latest onset is still presenting symptoms as of the evening of 12/26/2009.  Cool compresses have been administered for treatment and medical attention is being considered.
No additional AE; Improperly stored vaccine administered; This spontaneous report was received from a medical assistant concerning a 5-year-old female patient. The patient's concurrent condition, medical history, and concomitant medications were not provided.   On 02-AUG-2023, varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot# X006983, reported as x006983, which was captured as batch# upon internal validation, expiry date: 07-MAR-2025) was stored at -12.48 degree Celsius (C) for 1 hour 30 minutes and 0 seconds. There was no previous temperature excursion. On the same day, after temperature excursion, the patient was vaccinated with second dose of the improperly stored varicella virus vaccine live (Oka/Merck) (VARIVAX) subcutaneous injection 0.5 mL subcutaneously via left thigh as prophylaxis (product storage error). There were no symptoms reported. No additional adverse event (AE) was reported (no adverse event).
Dizziness; Chest pain; headache; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), CHEST PAIN (Chest pain), HEADACHE (headache) and MYALGIA (Muscle aches) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced DIZZINESS (Dizziness), CHEST PAIN (Chest pain), HEADACHE (headache) and MYALGIA (Muscle aches). At the time of the report, DIZZINESS (Dizziness), CHEST PAIN (Chest pain), HEADACHE (headache) and MYALGIA (Muscle aches) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported that she has not been taking any medications. She has not received any treatment for her symptoms.
Patient received Pediatric Pfizer vaccine as a booster dose instead of the adult Pfizer COVID19 vaccine.
On March 16, which was 4 days after vaccine, Pt experienced extreme malaise, fatigue and headache. These symptoms lasted for 5 days. She also had pain and lymphadenopathy left arm. She did not miss work but did limited desk work and cancelled scheduled home visits.
So this is slightly complicated:  I received a Janssen covid shot on 3/17 from batch number 1805022. I decided to get the Pfizer shot and got my first dose on 3/31 which is the one listed in this report on 3/31 batch number zr8737.  I got my second dose of Pfizer on 4/30 batch number EW0169. The first janssen vaccine left me ill for a few days including a day and a half in bed.  The first pfizer shot left me fatigued the following day.  The second pfizer I had no noticeable reaction.
began to cough repeatedly and have trouble with secretions after 1st vaccine transported to hospital via w/c
flu; Initial information received on 03-Jan-2023 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-healthcare professional.  This case involves a patient of unknown demographics who developed the flu after receiving vaccine Influenza vaccine.  It is unknown if the patient had any medical history, concomitant disease or risk factor.  Past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect Influenza vaccine produced by unknown manufacturer (strength, dose, formulation, frequency, lot number and expiry date: not reported) via unknown route in unknown administration site as prophylactic vaccination (Immunisation).  On an unknown date, the patient developed non-serious flu (influenza) (unknown latency) following the administration of influenza vaccine.  It is unknown if there were lab data/results available.  Action taken: Not applicable.  It was not reported if the patient received a corrective treatment for the event (flu).  At time of reporting, the outcome was Unknown for the event flu.
The back of her head is in a lot of pain; The neck is in a lot of pain; A spontaneous report was received from a consumer concerning a 30-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events back of her head is in a lot of pain, the neck is in a lot of pain.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 8 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) in the left arm for prophylaxis of COVID-19 infection.  On 24 Jan 2021, the patient experienced the event back of her head is in a lot of pain, the neck is in a lot of pain.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), back of her head is in a lot of pain was unknown.The outcome of event(s), the neck is in a lot of pain was unknown..; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
FEVER (UNABLE  TO CHECK TEMPERATURE); FATIGUE; HEADACHE; MUSCLE ACHES; NAUSEA; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018) dose was not reported, administered on 20-MAR-2021 at left arm for prophylactic vaccination. No concomitant medications were reported. On 21-MAR-2021, the subject experienced fever (unable to check temperature). On 21-MAR-2021, the subject experienced fatigue. On 21-MAR-2021, the subject experienced headache. On 21-MAR-2021, the subject experienced muscle aches. On 21-MAR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever (unable to check temperature), fatigue, headache, muscle aches and nausea was not reported. This report was non-serious.
Patient with large area of erythem noted to injection site immediately after injection Monitored x 30 minutes erythema decreased and no further reaction noted